$CYTR $ORPH $IBRX pietro23 can slam this stocktwits platform with as many rumors as he wants with "FDA" talks and "Multiple" bidders. Lies are difficult to dis prove. One fact you can not hide is Dr. Patrick Soon Shiong's name is on a patent that highlights dosing a known toxic chemo drug for 40 years - up to 40 X the FDA restricted dose amount. The patent is listed below read it. Shelving Aldoxorubicin + Delaying the NDA filing is part of CALOZ + KRIEGSMAN deal with SOON SHIONG costing $CYTR shareholders their time while Abraxane still brings in $1.2 Billion per year: so for $CYTR shareholders expecting an NDA filing in 2017 - this is what you really got [ Abraxane 2017,2018,2019,2020,2021] $1.2 BillionX 5 years = $6 billion dollars, $CYTR CALOZ + KRIEGSMAN accepted a "sweetheart" deal $13 million + $343 milestones protecting $6 billion in Abraxane sales as Celgene unloaded their wares to Bristol Myers for $74 billion dollars. patents.google.com/patent/W...
WO2019226774A1 - Modified doxorubicin compositions and methods - Google Patentsvia: Google